Immunic, Inc. to Participate in Investor Conferences in September ...Middle East

PR Newswire - News
Immunic, Inc. to Participate in Investor Conferences in September
NEW YORK, Sept. 1, 2022 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced participation in the following...

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunic, Inc. to Participate in Investor Conferences in September )

Also on site :